ANAGENICS LIMITED
ASX:AN1Pharmaceuticals, Biotechnology & Life SciencesToday’s holders own 89.0% of what they think they own, once every option and right converts.
Share count grew 114% in 24 months; 1 cash raise in 24 months; options/rights overhang 12% of shares
ANAGENICS LIMITED's ordinary share count expanded 113.6% between April 2024 and February 2026, its latest share-count filing, to 985M shares. In the past 24 months, the company has completed one capital raise, a A$2.3M placement in December 2025. Options and rights on issue could convert into 122M new shares, representing 12.4% of the current share count, all currently out of the money, with the nearest expiry in February 2029. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.
Quick answers · 5
When did AN1 last raise capital?
The last capital raise in Anagenics's filings is Placement of $2.3M announced 10 Dec 2025, one of 1 cash raises in 24 months.
How much placement capacity does AN1 have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does AN1 have?
In its quarterly cash report for the quarter ended 30 Sept 2026, Anagenics reported $532k of cash and estimated 53.2 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do AN1's options expire?
Unexercised options and rights equal 12.4% of Anagenics's shares on issue; the nearest expiry is Feb 2029.
How much has AN1's share count grown?
Anagenics has 985.5M shares on issue as at 28 Oct 2026, up 113.6% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 17 Apr 2026 | 3H · cancellation | AN1 : ORDINARY FULLY PAID | 985.5M | Appendix 3H |
| 12 Feb 2026 | 3G · unquoted | AN1 : ORDINARY FULLY PAID | 985.5M | Appendix 3G |
| 9 Feb 2026 | 2A · quoted issue | AN1 : ORDINARY FULLY PAID | 985.5M | Appendix 2A |
| 29 Jan 2026 | 3H · cancellation | AN1 : ORDINARY FULLY PAID | 570.8M | Appendix 3H |
| 29 Jan 2026 | 3H · cancellation | AN1 : ORDINARY FULLY PAID | 570.8M | Appendix 3H |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $0.005 today, 0 securities are in the money (0.0% of shares on issue). At double today’s price it is 122.3M (12.4% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| AN1AC | Options | Price-triggered | $0.008 | 12 Feb 2029 | 122.3M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 26 Feb 2026 | Alexander Beard | Buy on-market | 2.9M | — | — | $20k | 3Y notice |
| 16 May 2025 | Alexander Beard | Buy on-market | 56k | — | — | — | 3Y notice |
| 14 May 2025 | Alexander Beard | Buy on-market | 227k | — | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.